Cargando…
Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study
BACKGROUND: The Mayo protocol for liver transplantation in patients with unresectable perihilar cholangiocarcinoma is based on strict selection and neoadjuvant chemoradiotherapy. The role of neoadjuvant chemoradiotherapy in this scenario remains unclear. The aim of this study was to compare outcomes...
Autores principales: | Hoogwater, Frederik J H, Kuipers, Hendrien, de Meijer, Vincent E, Maulat, Charlotte, Muscari, Fabrice, Polak, Wojciech G, van Hoek, Bart, Jézéquel, Caroline, Alwayn, Ian P J, Ijzermans, Jan N M, Mohkam, Kayvan, Mabrut, Jean-Yves, Van Vilsteren, Frederike G I, Adam, Jean-Philippe, Chiche, Laurence, Chebaro, Alexandre, Boleslawski, Emmanuel, Dubbeld, Jeroen, Murad, Sarwa Darwish, Rayar, Michel, Porte, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083139/ https://www.ncbi.nlm.nih.gov/pubmed/37032423 http://dx.doi.org/10.1093/bjsopen/zrad025 |
Ejemplares similares
-
Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT)
por: Mohkam, Kayvan, et al.
Publicado: (2018) -
Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea
por: Chebaro, Alexandre, et al.
Publicado: (2023) -
Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020) -
Correction: End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial—HOPExt
por: Pradat, Pierre, et al.
Publicado: (2023) -
End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial—HOPExt
por: Pradat, Pierre, et al.
Publicado: (2023)